Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Thermo Fisher Scientific (NY:TMO)

567.20 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Oct 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Thermo Fisher Scientific

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
30 31 Next >
Mainz Biomed Announces Reverse Stock Split Soon After Collaborating With MedTech Giant Thermo Fisher Scientific
Mainz Biomed partners with Thermo Fisher to develop advanced colorectal cancer screening tools while enhancing ColoAlert for faster, accurate results. 
Via Benzinga
How Is The Market Feeling About Thermo Fisher Scientific?
 
Via Benzinga
Mainz Biomed Inks Major Deal To Develop A Next-Generation Cancer Test
Mainz Biomed Inks Major Deal To Develop A Next-Generation Cancer Test 
Via News Direct
Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases
From Thermo Fisher Scientific Inc.
Via Business Wire
Check Out What Whales Are Doing With TMO
 
Via Benzinga
Market Whales and Their Recent Bets on TMO Options
 
Via Benzinga
Earnings Outlook For Thermo Fisher Scientific
 
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,100 Today
 
Via Benzinga
(TMO) - Analyzing Thermo Fisher Scientific's Short Interest
 
Via Benzinga
The Oncology Bet Is Already Paying Off For Pfizer
With the downfall of Covid-19, pharmaceutical companies turned to oncology in search for their next growth story. Earlier in October, Pfizer Inc (NYSE: PFE) reported its third quarter revenue grew 14%... 
Via Benzinga
Healthcare Giant Thermo Fisher Scientific Inc. (NYSE: TMO) Inks Deal With Mainz Biomed (NASDAQ: MYNZ) To Develop And Commercialize Next Gen Colorectal Cancer Screening
Healthcare Giant Thermo Fisher Scientific Inc. (NYSE: TMO) Inks Deal With Mainz Biomed (NASDAQ: MYNZ) To Develop And Commercialize Next Gen Colorectal Cancer Screening 
Via News Direct
Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets
From Mainz BioMed NV
Via GlobeNewswire
$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,000 Today
 
Via Benzinga
Thermo Fisher Scientific to Present at the Wolfe 2024 Healthcare Conference on November 19, 2024
From Thermo Fisher Scientific Inc.
Via Business Wire
Thermo Fisher Scientific Declares Quarterly Dividend
From Thermo Fisher Scientific Inc.
Via Business Wire
Here's How Much $100 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth Today
 
Via Benzinga
Tradepulse Power Inflow Alert: Thermo Fisher Scientific Inc. Climbs Over 9 Points On Session After Alert
 
Via Benzinga
Thermo Fisher Scientific (TMO) Q3 2024 Earnings Call Transcript
TMO earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
Wall Street Slumps For Third Straight Day As Investor Sentiment Fades, Dollar Strength Resumes, Boeing Disappoints: What's Driving Markets Wednesday?
Wall Street is on track for its third consecutive day of losses as investors grow cautious about risky assets, awaiting more clarity on U.S. fiscal and monetary policies and scrutinizing the latest... 
Via Benzinga
Thermo Fisher Scientific Sails Through Q3 With Mixed Earnings, CEO Says In Great Position To Deliver 2024 Objectives
Thermo Fisher Scientific's Q3 revenue of $10.59 billion missed expectations. Adjusted EPS beat estimates but dropped year-over-year. Guidance for 2024 remains reaffirmed. 
Via Benzinga
Thermo Fisher Scientific Reports Third Quarter 2024 Results
From Thermo Fisher Scientific Inc.
Via Business Wire
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Each week, Benzinga’s Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and deserve attention. 
Via Benzinga
Novo Nordisk/AstraZeneca's Manufacturing Partner Thermo Fisher Questioned Over Manufacturing Lapses
Thermo Fisher's Greenville facility, one of the largest in the U.S., has faced repeated FDA regulatory violations. Key concerns include contamination prevention and inadequate equipment sterilization... 
Via Benzinga
Eli Lilly Leads S&P Health Care Stocks With 1,241% Gain. But The Others Aren't Slackers.
Eli Lilly has gained markedly over the past decade. But it's not the only S&P 500 health care stock to notch a bullish gain. 
Via Investor's Business Daily
Topics Stocks
Industry Leader Thermo Fisher's Contract Services Positioned For Growth Amid Popular Demand For GLP-1 Weight Loss Drugs, Analyst Initiates With Long-Term Growth Potential
Stephens initiated coverage on Thermo Fisher Scientific with an Overweight rating and $680 price target. The firm highlights the company's biopharma expansion, M&A strategy, and key growth areas like... 
Via Benzinga
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 23, 2024
From Thermo Fisher Scientific Inc.
Via Business Wire
“Nasdaq Stocks Set for Explosive Growth: BNZI, SEEL, PRSO, MSS, HSCS Revamp for Big Potential”
Via AB Newswire
Market Movers to Watch: Black Diamond (Nasdaq: BDTX), Peraso Inc. (NASDAQ: PRSO), Kaival Brands (NASDAQ: KAVL) among others w/Key Announcements
Via AB Newswire
Thermo Fisher Scientific Hosts 2024 Investor Day
From Thermo Fisher Scientific Inc.
Via Business Wire
Momentum Investing Gives You An Edge, Until It Doesn’t
Since 2020, momentum investing has generated significantly better returns than other strategies. Such is not surprising, given the massive amounts of stimulus injected into the financial system. 
Via Talk Markets
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
30 31 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.